2013
DOI: 10.1007/s00466-013-0858-3
|View full text |Cite
|
Sign up to set email alerts
|

Fluid–structure interaction simulation of pulsatile ventricular assist devices

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
44
0

Year Published

2013
2013
2022
2022

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 107 publications
(44 citation statements)
references
References 97 publications
0
44
0
Order By: Relevance
“…The computational FSI methodology for PVADs was presented in detail in Ref. 45. The linear FEM-based ALE-VMS technique 15,20,39,117 is used for the computation of blood and air flow in the respective chambers of the device.…”
Section: Pvad: Residence Time Computationsmentioning
confidence: 99%
See 2 more Smart Citations
“…The computational FSI methodology for PVADs was presented in detail in Ref. 45. The linear FEM-based ALE-VMS technique 15,20,39,117 is used for the computation of blood and air flow in the respective chambers of the device.…”
Section: Pvad: Residence Time Computationsmentioning
confidence: 99%
“…In an effort to enhance computational efficiency, a combination of a sparse-matrix-based and a matrix-free approach was used in the implementation of the quasi-direct nonmatching-interface FSI coupling technique (see Ref. 45 for details). Due to the large deformations of the membrane, the blood and air domain meshes need to be periodically regenerated.…”
Section: Pvad: Residence Time Computationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Results demonstrated that decreased residence time, presumed linked to thrombotic risk, could be achieved through automated shape optimization. [8890] Additional developments in VAD design and simulations were recently summarized in Marsden et al[91]…”
Section: Valves and Devicesmentioning
confidence: 99%
“…Examples of patient specific modeling include new surgical designs for congenital heart disease, 7,8,[16][17][18][19] risk assessment in coronary artery disease, 20,21 thrombotic risk stratification in Kawasaki disease 22 and cerebral and abdominal aneurysm treatment. 23,24 Device simulations have included evaluation of wall shear stress patterns in stents, 25,26 stent optimization, 27,28 ventricular assist devices, 29 device migration, 30 and pacemaker lead placement. 31 We are fast approaching a time when simulations, with proper validation, will be incorporated into day to day clinical practice.…”
Section: Introductionmentioning
confidence: 99%